Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis

Journal of Immunology

Volumn 161, Issue 4, 1998, Pages 1954-1961

  Pei, Yong ^a   Barber, Lisa A ^a   Murphy, Robert C ^c   Johnson, Christopher A ^c   Kelley, Susan W ^a   Dy, Lady C ^a   Fertel, Richard H ^d   Nguyen, Thanh M ^d   Williams, David A ^a,b   Travers, Jeffrey B ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^d THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; CYTOKINE; PROSTAGLANDIN E2; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ARACHIDONIC ACID METABOLISM; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; ENZYME INDUCTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; KERATINOCYTE; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN INDUCTION; SIGNAL TRANSDUCTION;

ARACHIDONIC ACID; CELL LINE; CYCLOOXYGENASE 2; CYTOKINES; DINOPROSTONE; EPIDERMIS; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; ISOENZYMES; KB CELLS; KERATINOCYTES; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED;

EID: 0032529395     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Prescott, S. M., G. A. Zimmerman, and T. M. McIntyre. 1990. Platelet-activating factor. J. Biol. Chem. 265:17381.
2. Pinckard, R. N., D. S. Woodard, H. J. Showell, M. J. Conklyn, M. J. Novak, and L. M. McManus. 1994. Structural and (patho)physiological diversity of PAF. Clin. Rev. Allergy 12:329.
3. Roth, M., M. Nauck, S. Yousefi, M. Tamm, K. Blaser, A. P. Perruchoud, and H. Simon. 1996. Platelet-activating factor exerts mitogenic activity and stimulates expression of interleukin 6 and interleukin 8 in human lung fibroblasts via binding to its functional receptor. J. Exp. Med. 184:191.
4. Levesque, J. P., A. Hatzfeld, and J. Hatzfeld. 1986. Fibrinogen mitogenic effect on hematopoeitic cell lines: control via receptor modulation. Prac. Natl. Acad. Sci. USA 83:6494.
5. Wilcox, R. W., R. L. Wykle, J. D. Schmitt, and L. W. Daniel. 1987. The degradation of platelet-activating factor and related lipids: susceptibility to phospholipases C and D. Lipids 22:800.
6. Travers, J. B., H. Sprecher, and R. H. Fertel. 1990. The metabolism of platelet-activating factor in human T lymphocytes. Biochim. Biophys. Acta 1042:193.
7. Bauldry, S. A., R. L. Wykle, and D. A. Bass. 1991. Differential actions of diacyl-and alkylacylglycerols in priming phospholipase A2, 5-lipoxygenase and acetyl-transferase activation in human neutrophils. Biochim. Biophys. Acta 1084:178.
8. Izumi, T., and T. Shimizu. 1995. Platelet-activating factor receptor: gene regulation and signal transduction. Biochim. Biophys. Acta 1259:317.
9. Poubelle, P. E., D. Gingras, C. Demers, C. Dubois, D. Harbour, J. Grassi, and M. Rola-Pleszczynski. 1991. Platelet-activating factor enhances the concomitant production of TNF-α and IL-1 by subsets of human monocytes. Immunology 72:181.
10. Ruis, N. M., J. K. Rose, and F. H. Valone. 1991. Tumor necrosis factor release by human monocytes stimulated with platelet-activating factor. Lipids 26:1060.
11. 2+ mobilization and eicosanoid release in human Mono Mac 6 cells. J. Immunol. 148:2186.
12. Barker, J., R. S. Mitra, C. E. M. Griffiths, V. M. Dixit, and B. J. Nickoloff. 1991. Keratinocytes as initiators of inflammation. Lancet 337:211.
13. Kondo, S., F. Kooshesh, and D. N. Sauder. 1997. Penetration of cytokines into basement membrane. J. Cell Physiol. 171:190.
14. Williams, C. W., and R. N. DuBois. 1996. Prostaglandin endoperoxide synthase: why two isoforms? Am. J. Physiol. 270:G393.
15. Langenbach, R., S. G. Morham, H. F. Tiano, C. D. Loftin, B. I. Ghanayem, P. C. Chulada, J. F. Mahler, C. A. Lee, E. H. Goulding, K. D. Kluckman, H. S. Kim, and O. Smithies. 1995. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 83:483.
16. Morham, S. G., R. Langenbach, C. D. Loftin, H. F. Tiano, N. Vouloumanos, J. C. Jennette, J. F. Mahler, K. D. Kluckman, A. Ledford, C. A. Lee, and O. Smithies. 1995. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 83:473.
17. Leong, J., M. Hughes-Fulford, N. Rakhlin, A. Habib, J. Maclouf, and M. E. Goldyne. 1996. Cyclooxygenases in human and mouse skin and cultured human keratinocytes: association of COX-2 expression with human keratinocyte differentiation. Exp. Cell Res. 224:79.
18. Muller-Decker, K., K. Scholz, F. Marks, and G. Furstenberger. 1995. Differential expression of prostaglandin H synthase isozymes during multistage carcinogenesis in mouse epidermis. Mol. Carcinog. 12:31.
19. DuBois, R. N., A. Radhika, B. S. Reddy, and A. J. Entingh. 1996. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology 110:1259.
20. Paquet, P., and G. E. Pierard. 1996. Interleukin-6 and the skin. Int. Arch. Allergy Immunol. 109:308.
21. Tuschil, A., C. Lam, A. Haslberger, and I. Lindley. 1992. Interleukin-8 stimulates calcium transients and promotes epithelial cell proliferation. J. Invest. Dermatol. 99:294.
22. Kulke, R., E. Bornscheuer, E. Schluter, J. Bartels, J. Rowert, M. Sticherling, and E. Christophers. 1998. The CXC receptor 2 is overexpressed in psoriatic epidermis. J. Invest. Dermatol. 110:90.
23. Michel, L., Y. Denizot, Y. Thomas, F. Jean-Louis, M. Heslan, J. Benveniste, and L. Dubertret. 1990. Production of PAF-acether by human epidermal cells. J. Invest. Dermatol. 95:576.
24. Travers, J. B., K. A. Harrison, C. A., Johnson, K. L. Clay, J. G. Morelli, and R. C. Murphy. 1996. Platelet-activating factor biosynthesis induced by various stimuli in human HaCaT keratinocytes. J. Invest. Dermatol. 107:88.
25. Travers, J. B., C. Johnson, K. L. Clay, T. Zekman, J. G. Morelli, and R. C. Murphy. 1997. Structural identification of platelet-activating factor in human keratinocytes. J. Lipid Mediat Cell Signal. 16:139.
26. Travers, J. B., J. C. Huff, M. Rola-Pleszczynski, E. W. Gelfand, J. G. Morelli, and R. C. Murphy. 1995. Identification of functional platelet-activating factor receptors on human keratinocytes. J. Invest. Dermatol. 105:816.
27. Mallet, A. I., and F. M. Cunningham. 1985. Structural identification of platelet-activating factor in psoriatic scale. Biochem. Biophys. Res. Commun. 126:192.
28. Grandel, K. E., R. S. Farr, A. A. Wanderer, T. Eisenstadt, and S. I. Wassermann. 1985. Association of platelet-activating factor with primary acquired cold urticaria. N. Engl. J. Med. 313:405.
29. Ishii, S., T. Nagase, F. Tashiro, K. Ikuta, S. Sato, I. Waga, K. Kume, J. Miyaazaki, and T. Shimizu. 1997. Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor. EMBO J. 16:133.
30. Boukamp, P., R. T. Petrussevska, D. Breitkreutz, J. Hornung, A. Markham, and N. E. Fusenig. 1988. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106:761.
31. Casals-Stengel, J. 1987. Effects of WEB 2086. a novel antagonist of platelet-activating factor, in active and passive anaphylaxis. Immunopharmacology 13: 117.
32. Sheppard, G. S., D. Pireh, G. Carrera, M. Bures, H. R. Heyman, D. Steinman, S. K. Davidsen, J. Phillips, D. H. Guinn, P. D. May, R. G. Conway, D. A. Rhein, W. C. Calhoun, D. H. Albert, T. J. Magoc, G. W. Carter, and J. B. Summers. 1994. 3-(2-(3-Pyridinyl)thiazolidin-4-oyl)indoles, a novel series of platelet-activating factor antagonists. J. Med. Chem. 37:2011.
33. Eagle, H. 1955. Propagation in a fluid medium of a human epidermoid carcinoma strain KB. Proc. Soc. Exp. Biol. Med. 89:362.
34. Miller, A. D., and G. J. Rosman. 1989, Murine stem cell retroviral constructs. Biotechniques 7:980.
35. Apperley, J. F., B. D. Luskey, and D. A. Williams. 1991. Retroviral gene transfer of human adenosine deaminase in murine hematopoelic cells. Blood 78:310.
36. Markowitz, D., S. Goff, and A. Bank. 1988. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J. Virol. 62:1120.
37. Markowitz, D., S. Goff, and A. Bank. 1988. Construction and use of a safe and efficient amphotrophic packaging cell line. Virology 167:400.
38. Sambrook, J., E. F. Fritsch, and T. Maniatis, eds. 1995. Molecular Cloning: A Laboratory Manual, 2nd Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
39. Thivierge, M., and M. Rola-Pleszczynski. 1995. Up-regulation of inducible cyclooxygenase gene expression by platelet-activating factor in activated rat alveolar macrophages. J. Immunol. 154:6593.
40. Takano, T., Z. Honda, C. Sakanaka, T. Izumi, K. Kameyama, K. Haga, T. Haga, K. Kurokawa, and T. Shimizu. 1994. The role of cytoplasmic tail phosphorylation sites of the platelet-activating factor receptor in agonist-induced desensitization. J. Biol. Chem. 269:22453.
41. Scatchard, G. 1949. The attractions of proteins for small molecules and ions. Ann. NY Acad. Sci. 51:660.
42. Fertel, R., J. Z. Yetiv, M. A. Coleman, R. D. Schwarz, J. E. Greenwald, and J. R. Bianchine. 1981. Formation of antibodies to prostaglandins in the yolk of chicken eggs. Biochem. Biophys. Res. Commun. 102:1028.
43. Tessner, T. G., J. T. O'Flaherty, and R. L. Wykle. 1989. Stimulation of platelet-activating factor biosynthesis by a non-metabolizable analog of platelet-activating factor and influence of arachidonic acid metabolites. J. Biol. Chem. 264:4794.
44. Spangelo, B. L., and W. D. Jarvis. 1996. Lysophosphatidylcholine stimulates interleukin-6 release from rat anterior pituitary cells in vitro. Endocrinology 137: 4419.
45. Smiley, P. L., K. E. Stremler, S. M. Prescott, G. A. Zimmerman, and T. M. McIntyre. 1991. Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor. J. Biol. Chem. 266:11104.
46. Nakamura, M., Z. Honda, I. Waga, T. Matsumoto, M. Noma, and T. Shimizu. 1992. Endotoxin transduces calcium signalling via the platelet-activating factor receptor. FEBS Lett. 314:125.
47. Cundell, D., N. P. Gerard, C. Gerard, C., I. Idanpaan-Helkkila, and E. I. Tuomanen. 1995. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 377:435.
48. Rola-Pleszczynski, M., M. Thiverge, S. Quellet, S., P. Dagenais, J. L. Parent, and J. Stankova. 1995. Cytokines and eicosanoids regulate PAF receptor gene expression. Adv. Prostaglandin Thromboxane Leukotriene Res. 23:287.
49. Miwa, M., T. Miyake, T. Yamanaka, J. Sugatani, Y. Suzuki, S. Sakata, Y. Araki, and M. Matsumato. 1988. Characterization of platelet-activating factor (PAF) acetylhydrolase deficiency: correlation between deficiency of PAF acetyl hydrolase and respiratory symptoms in asthmatic children. J. Clin. Invest. 82:1983.
50. Wu, T., R. D. Rieves, C. Logun, and J. H. Shelhamer. 1995. Platelet-activating factor stimulates eicosanoid production in cultured feline tracheal epithelial cells. Lung 173:89.
51. Hurst, J. S., and H. E. Bazan. 1995. Platelet-activating factor preferentially stimulates the phospholipase A2/cyclooxygenase cascade in the rabbit cornea. Curr. Eye Res. 14:769.
52. Marcheselli, V. L., and N. G. Bazan. 1996. Sustained induction of prostaglandin endoperoxide synthetase-2 by seizures in the hippocampus. Inhibition by a platelet-activating factor receptor antagonist. J. Biol. Chem. 271:24794.
53. Pentland, A. P., and P. Needleman. 1986. Modulation of keratinocyte proliferation in vitro by endogenous prostaglandin synthesis. J. Clin. Invest. 77:246.
54. Evans, C. B., S. Pillai, and M. E. Goldyne. 1993. Endogenous prostaglandin E2 modulates calcium-induced differentiation in human skin keratinocytes. Prostaglandin Leukotrienes Essent. Fatty Acids 49:777.
55. Standiford, T. J., S. L. Kunkel, M. W. Rolfe, H. L. Evanoff, R. M. Allen, and R. M. Strieter. 1992. Regulation of alveolar macrophage- and blood monocyte derived interleukin-8 by prostaglandin E2 and dexamethasone. Am. J. Respir. Cell Mol. Biol. 6:75.
56. Watanabe, M., M. Yamada, S. Mue, and K. Ohuchi. 1996. Enchancement by cyclo-oxygenase inhibitors of platelet-activating factor production in thapsigargin-stimulated macrophages. Br. J. Pharmacol. 116:2141.
57. Thivierge, M., and M. Rola-Pleszczynski. 1992. Platelet-activating factor enhances interleukin-6 production by alveolar macrophages. J. Allergy Clin. Immunol. 90:796.
58. Biffl, W. L., E. E. Moore, F. A. Moore, and C. C. Burnett, Jr. 1996. Interleukin-6 stimulates neutrophil production of platelet-activating factor. J. Leukocyte Biol. 59:569.
59. Bussolino, F., M. Sironi, E. Bocchietto, and A. Mantovani. 1992. Synthesis of platelet-activating factor by polymorphonuclear neutrophils stimulated with interleukin-8. J. Biol. Chem. 267:14598.